Application starts next Monday (29). Announcement was made by the governor of the Federal District, Ibaneis Rocha, through social networks.
The treatment, the institution reported, is carried out with two daily doses of the PF-07321332 compound associated with Ritonavir for five consecutive days.
As it stands today, Comirnaty’s package insert stipulates that each person should receive only two doses. The permit for a booster dose hinges on the approval of the Brazilian watchdog, tasked with certifying the security and efficiency of vaccines.
Anvisa now wants data from the studies conducted by the company on the administration of the extra shot, as well as the results obtained by the research. A meeting with Pfizer representatives on the topic has also been requested.
The expansion was approved, Anvisa stated, after studies were unveiled by laboratories indicating the safety and efficiency of the vaccine for this group. The research was carried out overseas and assessed by the Brazilian watchdog.
Português 
Español 
